Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for ... in the brain that bind to the neurotransmitters serotonin and dopamine. Caplyta is usually taken as ...

Atypical antipsychotic drugs have been shown to be more efficacious in treating cognitive disturbances of schizophrenia compared with typical antipsychotic drugs. Serotonin (5-hydroxytryptamine [5 ...

An imbalance between neurotransmitters such as dopamine and serotonin, can cause schizophrenia. A study, published in Frontiers in Psychiatry, lists dopamine as an inhibitory neurotransmitter that ...

Similarly, the first steps toward alleviating our ignorance of schizophrenia came with the ... reviews influences of the 'safe' selective serotonin reuptake inhibitors (SSRIs).

Generally, the pathophysiology of schizophrenia is believed to be determined by imbalances in neurotransmitters, in particular dopamine and serotonin, and in four neural pathways in the brain ...

They called it the “VIVA ZYPREXA” campaign to off label market Eli Lilly Zyprexa as a fix for unapproved usage. Zyprexa (Olanzapine) is known as an atypical antipsychotic It’s ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

Examples of neurotransmitters include serotonin, dopamine, and norepinephrine. There are several types of antidepressants on the market. They all work slightly differently by targeting certain ...